124 related articles for article (PubMed ID: 6358159)
1. A tumor/normal tissue advantage for low dose rate neutron brachytherapy.
Maruyama Y; Feola JM; Beach JL
Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1715-21. PubMed ID: 6358159
[TBL] [Abstract][Full Text] [Related]
2. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future.
Maruyama Y; Mesina J; Yudelev M; Wierzbicki J; Deppe G; Porter AT
Strahlenther Onkol; 1994 May; 170(5):253-63. PubMed ID: 8197547
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of time-dose and fractionation for 252Cf neutrons in preoperative bulky/barrel-cervix carcinoma radiotherapy.
Maruyama Y; Wierzbicki J
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1561-8. PubMed ID: 2262382
[TBL] [Abstract][Full Text] [Related]
4. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic dosimetry for Cf-252 neutron brachytherapy of pelvic cancer.
Maruyama Y; Beach JL; Hazle J; Ashtari M; Schroy CB; Olson MH
Int J Radiat Oncol Biol Phys; 1985 May; 11(5):927-35. PubMed ID: 3921501
[TBL] [Abstract][Full Text] [Related]
6. [Principles of dosimetric planning in contact therapy with highly active Cf-252 sources].
Chekhonadskij VN; Merkle K
Strahlenther Onkol; 1987 Nov; 163(11):742-5. PubMed ID: 3686338
[TBL] [Abstract][Full Text] [Related]
7. Schedule in Cf-252 neutron brachytherapy: complications after delayed implant therapy for cervical cancer in a phase II trial.
Maruyama Y; van Nagell JR; Yoneda J; Gallion HH; DePriest P; Feola JM; Wierzbicki J
Am J Clin Oncol; 1993 Apr; 16(2):168-74. PubMed ID: 8452113
[TBL] [Abstract][Full Text] [Related]
8. A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy.
Rivard MJ; Melhus CS; Zinkin HD; Stapleford LJ; Evans KE; Wazer DE; Odlozilíková A
Radiat Res; 2005 Sep; 164(3):319-23. PubMed ID: 16137205
[TBL] [Abstract][Full Text] [Related]
9. Scheduling of hypoxic-tumor therapy using neutron brachytherapy.
Maruyama Y; Beach JL; Feola J
Radiology; 1980 Dec; 137(3):775-81. PubMed ID: 6777827
[TBL] [Abstract][Full Text] [Related]
10. Rapid clearance of advanced pelvic carcinomas by low dose rate 252Cf neutron therapy.
Maruyama Y
Radiology; 1979 Nov; 133(2):473-5. PubMed ID: 493540
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Cf 252-neutrons at low dose rates.
Kal HB
Int J Radiat Oncol Biol Phys; 1982 Sep; 8(9):1549-54. PubMed ID: 7141930
[TBL] [Abstract][Full Text] [Related]
12. Cf-252 neutron brachytherapy of short duration for bulky neck tumors.
Maruyama Y; Beach JL
Int J Radiat Oncol Biol Phys; 1986 May; 12(5):761-770. PubMed ID: 3011711
[TBL] [Abstract][Full Text] [Related]
13. Californium-252 neutron curietherapy for advanced cervical cancer.
Maruyama Y; Bell PR; Yoneda J; Van Nagell JR
Oncology; 1982; 39(4):209-15. PubMed ID: 7088471
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
Tacev T; Vacek A; Ptácková B; Strnad V
Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
[TBL] [Abstract][Full Text] [Related]
15. Cure of cervical cancer using 252Cf neutron brachytherapy.
Maruyama Y; van Nagell JR; Yoneda J; Donaldson ES; Gallion HH; Higgins R; Kryscio RJ
Strahlenther Onkol; 1990 May; 166(5):317-21. PubMed ID: 2190346
[TBL] [Abstract][Full Text] [Related]
16. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of brachytherapy with californium-252 neutrons versus cesium-137 photons for eradication of bulky localized cervical cancer: single-institution study.
Maruyama Y; van Nagell JR; Yoneda J; Donaldson E; Gallion H; Higgins R; Powell D; Turner C; Kryscio R
J Natl Cancer Inst; 1988 Jun; 80(7):501-6. PubMed ID: 3367388
[TBL] [Abstract][Full Text] [Related]
18. Neutron and gamma dose distribution for tandem, tandem and ovoid and plaque for intracavitary 252Cf therapy of cervix carcinoma.
Maruyama Y; Tai DL; Beach JL
Radiat Med; 1983; 1(3):230-6. PubMed ID: 6390538
[TBL] [Abstract][Full Text] [Related]
19. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.
Qian S; Ye L; Tian YH; Wang LG; Huang ZP; Li F; Hou B; Song N; Chen J; Liu Y; Liu X; Zhou T
Chin J Cancer; 2017 Feb; 36(1):24. PubMed ID: 28245859
[TBL] [Abstract][Full Text] [Related]
20. Second primary malignancies after high-dose-rate
Janulionis E; Samerdokiene V; Valuckas KP; Atkocius V; Rivard MJ
Brachytherapy; 2018; 17(5):768-774. PubMed ID: 29895451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
